Načítá se...
TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer
Head and neck cancer (SCCHN) is a common, aggressive, treatment-resistant cancer with a high recurrence rate and mortality, but the mechanism of treatment-resistance remains unclear. Here we describe a mechanism where the AAA-ATPase TRIP13 promotes treatment-resistance. Overexpression of TRIP13 in n...
Uloženo v:
Hlavní autoři: | , , , , , , , , , , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
2014
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4130352/ https://ncbi.nlm.nih.gov/pubmed/25078033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms5527 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|